SCHEMBL1116168

SCHEMBL1116168

NC1=N/C(=C/c2ccc(-c3ncccn3)o2)C(=O)N1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 2/20 0.42
▸ PIK3CG P48736 3/20 0.42
▸ PIK3CA P42336 2/20 0.42
▸ DYRK3 O43781 1/20 0.41
▸ PIM1 P11309 1/20 0.41
▸ CSNK2A2 P19784 1/20 0.41
▸ CSNK2B P67870 1/20 0.41
▸ CSNK2A1 P68400 1/20 0.41
▸ DYRK1A Q13627 1/20 0.41
▸ CSNK2A3 Q8NEV1 1/20 0.41
▸ DYRK2 Q92630 1/20 0.41
▸ DYRK1B Q9Y463 1/20 0.41
▸ HTR2A P28223 4/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CLK1 P49759 1/20 0.38
▸ CLK2 P49760 1/20 0.38
▸ CLK4 Q9HAZ1 1/20 0.38
▸ RAB9A P51151 5/20 0.36
▸ MEN1 O00255 5/20 0.36
▸ KMT2A Q03164 5/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1116169 1.00 CA2 (0.42) CA2PIK3CGPIK3CADYRK3PIM1
SCHEMBL1116161 0.81 HTR2A (0.42) CA2PIK3CGPIK3CADYRK3PIM1
SCHEMBL1116264 0.75 HTR2A (0.54) CA2PIK3CGHTR2ACA1CLK1
SCHEMBL1116262 0.75 HTR2A (0.54) CA2PIK3CGHTR2ACA1CLK1
SCHEMBL1228309 0.74 BRAF (0.60) PIK3CGMEN1KMT2ASMN1; SMN2MAPT
SCHEMBL1116165 0.74 CA2 (0.38) CA2DYRK3PIM1CSNK2A2CSNK2B
SCHEMBL1228305 0.74 BRAF (0.60) PIK3CGMEN1KMT2ASMN1; SMN2MAPT
SCHEMBL1116220 0.72 DYRK2 (0.64) PIK3CGPIK3CADYRK3PIM1CSNK2A2
SCHEMBL1116223 0.72 DYRK2 (0.64) PIK3CGPIK3CADYRK3PIM1CSNK2A2
SCHEMBL6859360 0.72 GSK3A (0.43) PIK3CGPIK3CAMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011015646-A2 FURAN-IMIDAZOLONE DERIVATIVES, FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS NOSCIRA, S.A. (ES) 2011-02-10 — — WO disclosed
EP-2281824-A1 Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders NOSCIRA, S.A. (ES) 2011-02-09 — — EP disclosed
Send feedback